Dianna Ammons Johnson

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.2MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20192025
AwardsPatents
Federal awards as principal investigator

8 awards · $3.2M

DateAgencyAwardAmountCompany
Sep 16, 2025NIHSBIR Phase II
Late-stage Pre-clinical Development and GMP Production of a First-in-Class Extended Release IOP-lowering Formulation
$1.0MTavo Biotherapeutics
Aug 29, 2024NIHSBIR Phase II
Late-stage Pre-clinical Development and GMP Production of a First-in-Class Extended Release IOP-lowering Formulation
$1.1MTavo Biotherapeutics
Feb 17, 2024NIHSBIR Phase I
Development of a novel depot delivery system for a glaucoma therapeutic
$82KTavo Biotherapeutics
Dec 20, 2023NIHSBIR Phase I
Development of a novel depot delivery system for a glaucoma therapeutic
$57KTavo Biotherapeutics
Aug 31, 2023NIHSBIR Phase I
Development of a novel depot delivery system for a glaucoma therapeutic
$336KTavo Biotherapeutics
May 24, 2021NIHSBIR Phase I
Neuroprotective Properties of a Novel Glaucoma Drug and Formulation
$357KTavo Biotherapeutics
Jan 28, 2020NIHSBIR Phase I
Extended release formulation of a new IOP lowering drug for improved treatment of glaucoma
$55KTavo Biotherapeutics
May 28, 2019NIHSBIR Phase I
Extended release formulation of a new IOP lowering drug for improved treatment of glaucoma
$225KTavo Biotherapeutics
Among 4,078 researchers in Biotech

Peer ranks

Federal funding#561
Awards as PI#190
Patents#273
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.